| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000029248 |
| Receipt No. | R000033396 |
| Official scientific title of the study | Effect of exercise on sarcopenia in patients with overt hepatic encephalopathy |
| Date of disclosure of the study information | 2017/10/05 |
| Last modified on | 2017/09/24 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of exercise on sarcopenia in patients with overt hepatic encephalopathy | |
| Title of the study (Brief title) | Exercise and overt hepatic encephalopathy | |
| Region |
|
|
| Condition | ||
| Condition | Overt hepatic encephalopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Scarce data are currently available for the effect of exercise on sarcopenia for OHE patients receiving PE. The aims of the current study are to prospectively examine the effect of exercise on sarcopenia in patients with OHE. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Assessment of sarcopenia using BIA |
| Key secondary outcomes | Clinical time course in baseline characteristics, brain MRI findings and number connection test. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Physical exercise
In the physical exercise group, we will conduct guidance to study participants at the outpatient nutrition guidance room. We will also instruct them to do exercise with more than 3 metabolic equivalents (Mets) for 60 minutes per day and to do exercise more than 23 Mets per week. |
||
| Interventions/Control_2 | Standard pharmacotherapy | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with OHE with the age of twenty years or older receiving pharmacotherapy | |||
| Key exclusion criteria | 1.Patients with severe depression or psychiatric disorder
2.Patients with severe OHE who are expected to be difficult to participate in this study. 3.Patients with severe underlying diseases or advanced malignancies. 4.Pregnant or lactating female patients 5.Patients who were judged to be inappropriate for the study subjects |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Shuhei Nishiguchi |
| Organization | Hyogo college of medicine |
| Division name | Division of hepatopancreatology, department of internal medicine |
| Address | 1-1, Mukogawacho, Nishinomiyashi, Hyogo, Japan |
| TEL | 0798-45-6111 |
| kantan@hyo-med.ac.jp | |
| Public contact | |
| Name of contact person | Kazunori Yoh |
| Organization | Hyogo college of medicine |
| Division name | Division of hepatopancreatology, department of internal medicine |
| Address | 1-1, Mukogawacho, Nishinomiyashi, Hyogo, Japan |
| TEL | 0798-45-6111 |
| Homepage URL | |
| mm2wintwin@yahoo.co.jp | |
| Sponsor | |
| Institute | Hyogo college of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hyogo college of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033396 |